tirzepatide weight loss efficacy vs semaglutide outperformed weight-loss drug results in real world patients, study shows Tirzepatide generates 7% greater weight

it delivers the same dual GLP1/GIP mechanism for appetite control and metabolic support via absorption through the mouth lining

Weight loss results average around 8%, roughly 60% less than what Tirzepatide achieves

The risk of microbial contamination becomes real

But raw percentages can be misleading without understanding the trial designs, patient populations, and timelines involved

As a result, some patients may have been misclassified if PCOS was listed as a secondary or historical condition rather than an active clinical diagnosis

Your consultation is assessed by a qualified prescriber to determine whether the medication is suitable for you